380 related articles for article (PubMed ID: 26320372)
1. The treatment of hyperuricemia.
Gliozzi M; Malara N; Muscoli S; Mollace V
Int J Cardiol; 2016 Jun; 213():23-7. PubMed ID: 26320372
[TBL] [Abstract][Full Text] [Related]
2. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
Bove M; Cicero AF; Veronesi M; Borghi C
Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
[TBL] [Abstract][Full Text] [Related]
3. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
Ernst ME; Fravel MA
Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function.
Bove M; Cicero AFG; Borghi C
Curr Hypertens Rep; 2017 Oct; 19(12):95. PubMed ID: 29071435
[TBL] [Abstract][Full Text] [Related]
5. Uric acid lowering therapy in cardiovascular diseases.
Volterrani M; Iellamo F; Sposato B; Romeo F
Int J Cardiol; 2016 Jun; 213():20-2. PubMed ID: 26386814
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.
Chen C; Lü JM; Yao Q
Med Sci Monit; 2016 Jul; 22():2501-12. PubMed ID: 27423335
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
[TBL] [Abstract][Full Text] [Related]
8. Reducing effect of mangiferin on serum uric acid levels in mice.
Niu Y; Lu W; Gao L; Lin H; Liu X; Li L
Pharm Biol; 2012 Sep; 50(9):1177-82. PubMed ID: 22881143
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitors of xanthine oxidoreductase].
Okamoto K
Nihon Rinsho; 2008 Apr; 66(4):748-53. PubMed ID: 18409526
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
11. [Gout and cardiovascular risk].
Němec P
Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
[TBL] [Abstract][Full Text] [Related]
12. Recent approaches to gout drug discovery: an update.
Otani N; Ouchi M; Kudo H; Tsuruoka S; Hisatome I; Anzai N
Expert Opin Drug Discov; 2020 Aug; 15(8):943-954. PubMed ID: 32329387
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.
Terkeltaub R; Bushinsky DA; Becker MA
Arthritis Res Ther; 2006; 8 Suppl 1(Suppl 1):S4. PubMed ID: 16820043
[TBL] [Abstract][Full Text] [Related]
14. Natural Products and Extracts as Xantine Oxidase Inhibitors - A Hope for Gout Disease?
Orhan IE; Deniz FSS
Curr Pharm Des; 2021; 27(2):143-158. PubMed ID: 32723252
[TBL] [Abstract][Full Text] [Related]
15. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
[TBL] [Abstract][Full Text] [Related]
16. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
17. Gout and hyperuricemia.
Chilappa CS; Aronow WS; Shapiro D; Sperber K; Patel U; Ash JY
Compr Ther; 2010; 36():3-13. PubMed ID: 21229813
[TBL] [Abstract][Full Text] [Related]
18. Effects of Pimenta pseudocaryophyllus extracts on gout: Anti-inflammatory activity and anti-hyperuricemic effect through xantine oxidase and uricosuric action.
Ferrari FC; Lemos Lima Rde C; Schimith Ferraz Filha Z; Barros CH; de Paula Michel Araújo MC; Antunes Saúde-Guimarães D
J Ethnopharmacol; 2016 Mar; 180():37-42. PubMed ID: 26778678
[TBL] [Abstract][Full Text] [Related]
19. New medications in development for the treatment of hyperuricemia of gout.
Diaz-Torné C; Perez-Herrero N; Perez-Ruiz F
Curr Opin Rheumatol; 2015 Mar; 27(2):164-9. PubMed ID: 25603039
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]